All SEC Filings :: Xenetic Biosciences, Inc. (XBIO)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
11/09/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1			19
10/21/22	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
10/17/22	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material			3
10/17/22	DEF 14A	Definitive proxy statements			26
10/13/22	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.			5
10/12/22	8-K	Current report filing			2
10/03/22	PRE 14A	Preliminary proxy statement not related to a contested matter or merger/acquisition			25
08/12/22	8-K	Current report filing Related Documents EX-99.1			4
08/11/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-31.1 EX-31.2 EX-32.1			60
07/07/22	8-K	Current report filing Related Documents EX-99.1			4

All SEC Filings